Elliot Hospital Of The City Of Manchester

Elliot Hospital of the City of Manchester, doing business as Elliot Hospital, is a nonprofit, tax-exempt healthcare provider located in Manchester, New Hampshire, that has been registered to receive federal awards since September 30, 2004. As a comprehensive hospital and healthcare system, Elliot Hospital provides specialized medical services and laboratory support to the federal government through both prime contract and grant awards. The organization serves as a key healthcare partner for federal agencies, particularly the Department of Veterans Affairs, and has demonstrated consistent capability in delivering clinical services, workforce development, and community health initiatives across Southern New Hampshire.

Through federal contract awards, Elliot Hospital has primarily provided STAT (immediate) and non-STAT laboratory testing services along with blood irradiation and blood product services to support veterans' healthcare needs. All contract awards have been issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 (VA-VHA VISN 1) under Blanket Purchase Agreement (BPA) mechanisms without set-aside designations, reflecting the hospital's competitive standing in open federal procurement. Contract values have historically ranged from approximately $8,000 to $198,769.50, with individual task orders awarded annually under the overarching BPA vehicle. The most recent contract award, effective January 1, 2026 through December 31, 2026, carries a ceiling value of $8,000 for STAT laboratory testing and blood irradiation services performed at the hospital's Manchester location. These contracts streamline the VA's procurement of critical medical support services while maintaining spending oversight through established healthcare partnerships supporting veteran populations in the region.

Elliot Hospital has received three prime federal grant awards addressing significant public health and workforce development priorities in Southern New Hampshire. The Healthcare Systems Bureau of the Department of Health and Human Services awarded a $577,000 Project Grant (CFDA 93.493) under Congressional Directives funding, effective September 30, 2024 through September 29, 2027, to upgrade mammography imaging capabilities at the Elliot Breast Health Center with high-resolution 3D mammography technology that reduces patient radiation exposure by approximately 50% while improving pathology detection and radiologist efficiency. The SAMHSA Center for Substance Abuse Treatment awarded a Project Grant effective September 30, 2023 through September 29, 2028, to support the "Live Free" initiative, which expands medication-assisted treatment (MAT) and psychosocial services targeting justice-involved individuals with opioid use disorders in Manchester, the epicenter of New Hampshire's drug crisis, providing comprehensive recovery support through an interdisciplinary team approach. The Employment and Training Administration awarded a Project Grant effective June 1, 2023 through May 31, 2028, to expand and diversify the pipeline of nursing professionals at the LPN, RN, and MSN levels across the Southern New Hampshire region, targeting 300 participants and addressing health professional shortage areas through educational programs designed to support diversity, inclusion, and equity for underserved community members. Additionally, Elliot Hospital has received multiple federal grant sub-awards from the New Hampshire Department of Safety and the New Hampshire Department of Health and Human Services related to disaster recovery operations, medication-assisted treatment for opioid use disorders, and maternal opioid misuse intervention models, demonstrating sustained engagement in addressing substance use disorders and public health emergencies.

Elliot Hospital holds a single-award Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1, effective January 1, 2026 through December 31, 2030, with a ceiling value of $39,287.51. This indefinite delivery vehicle is structured to provide STAT and non-STAT laboratory testing services along with blood irradiation services performed at the hospital's Manchester, New Hampshire location, supporting the VA's comprehensive healthcare mission for veterans in the region. The BPA encompasses multiple task orders with a combined anticipated value of $420,317.20, demonstrating the VA's intent to establish a sustained, multi-year partnership for specialized laboratory and transfusion support services. The initial task order awarded under this IDV in 2026 is valued at $8,000 for the first performance year, and the BPA structure enables the VA to efficiently procure critical medical support services while maintaining spending oversight through defined ceiling values and annual performance periods, leveraging the established healthcare partnership that has been developed through years of successful contract performance.